The relevance of "Nonsmoking-associated lung cancer" in India: A single-centre experience.

Background: Lung cancer remains a major cause of morbidity and mortality worldwide, accounting for more deaths than any other cancer cause. Aim: The aim of this study was to analyze the clinical profile and the epidemiological trends in lung cancer patients from a single centre with an emphasis on the smoking practices. Materials and Methods: This is a retrospective analysis of prospectively collected data of 258 consecutive hospital in-patients with a proven diagnosis of lung cancer at a tertiary care oncology centre between 2003 and 2007. Results: The median age of patients in our study was 56 years; the male to female ratio was approximately 3.5:1. Non-small-cell lung cancer (NSCLC) was the predominant histology in 224 patients; the histology in the remaining 34 patients was small-cell carcinoma. Within NSCLC, the most common histology was adenocarcinoma followed by squamous cell carcinoma. One hundred and two patients were never-smokers as compared to 156 patients who were ever-smokers. Among the smokers, the majority of them were found to be cigarette smokers compared to 28.2% bidi smokers. There was a very significant correlation found with adenocarcinoma among nonsmokers, and with squamous cell carcinoma among the smokers compared to non-smokers. Conclusions: Our study suggests that the epidemiology of lung cancer in India is possibly changing, with close to 40% of our lung cancer patients being nonsmokers. More importantly, our study reflects the global trend of rise in adenocarcinoma histology. These observations need to be substantiated in similar studies of larger magnitude, preferably population-based.

Epidemiology of lung cancer in India: Focus on the differences between non-smokers and smokers: A single-centre experience.

Context: Lung cancer has varied epidemiology depending on the geographic region. Globally, there have been important changes in incidence trends amongst men and women, histology, and incidence in non-smokers. Indian epidemiological data on lung cancer is scarce. Aims: We set out to study the epidemiological patterns and clinical profile of lung cancer in India. Materials and Methods: We interviewed patients discussed in the thoracic oncology multidisciplinary meetings between 2008 and 2009. Demographic data, smoking history, place of residence, histology, stage at presentation, and treatment details were collected. Data was entered and analyzed in SPSS. Results: There were 489 patients, with a median age of 56 years, of which 255 (52%) were non-smokers and 234 (48%) were smokers. One hundred and thirty-three patients had consumed smokeless tobacco. The male-to-female ratio was 3.5:1. Sixty-nine patients (14.1%) were incorrectly diagnosed and treated with anti-tuberculosis treatment, which delayed the diagnosis of lung cancer by four months. Eight percent of patients had small-cell carcinoma; of the 92% patients with non-small-cell carcinoma (NSCLC), the most common histology was adenocarcinoma (43.8%), followed by squamous cell (26.2%), large cell (2.1%) and other (8.3%). Eighteen percent of patients were diagnosed by cytology, therefore were diagnosed as NSCLC, without further histologic subtyping. Most patients (43%) were in Stage III at presentation. Lung followed by bone were the common sites of metastases. The majority of the patients (49%) received palliative chemotherapy. Among definitive therapy, concurrent chemo-radiation (13%) was offered more frequently than surgery (6%). Conclusion: Considerably higher numbers of Indian patients with lung cancer are non-smokers, compared to the West. The global trend of rise in adenocarcinoma is paralleled in India. Non-tobacco-related risk factors need further investigation.

Patho-epidemiology of lung cancer in Karachi (1995-2002).

The objective of the study was to provide an overview of the demographics of lung cancer, the number one cancer killer of men in Karachi South (1995-2002). Lung cancer cases recorded at Karachi Cancer Registry during 1st January 1995 to 31st December 2004 were analyzed. To allow for maximum data completion, cases recorded from 1st January 1995 to 31st December 2002 were included for final analysis. Trends were studied by analyzing the age standardized incidence rates (ASR)s in 2 time periods, 1995-1997 and 1998-2002. Odds ratio for sex, age-groups, ethnicity, religion, and residence by socio-economic categories were calculated by considering all malignancies (except tobacco-associated malignancies) for each group, registered at KCR for the same period as controls. Cancer of the lung ranked the most frequent malignancy in men in Karachi in the entire 1995-2002 period, though it did not feature amongst the first 10 malignancies in the females. In the 1995-1997 period, the ASR per 100,000 population for cancer of the lung was 21.4 and 2.9 in males (M) and females (F) respectively. The mean age of the patients was 60.4 years (95% CI, 59.1-61.7) M and 53.7 years (95% CI 48.9-58.5) F. In the 1998-2002 period the incidence rate increased to 25.5 per 100,000 (M) and 4.2 per 100,000 (F). Thus between 1995 and 2002, the incidence of lung cancer registered a 19% increase in men and almost 100% in women. The component of adenocarcinoma in females remained stable during 8 years, but increased 55% in males. Histologic confirmation was 80%; majority of cancer cases presented as grade 3 and grade 4 lesions (62.3%), and were discovered at advanced stages (stage III 35.7%; stage IV 55.8%).The odds ratio (OR) in men was 4.5 (95% CI 3.7; 5.4). The risk of developing lung cancer increased with age, the highest risk being observed in the 65+ age group. A marginally higher risk was observed in the higher socio-economic categories for men and in the lower socio-economic categories for women. A higher risk was also observed for men who were residing along the coastal belt, and for ethnicities belonging to Southern Pakistan (Sindhi and Mohajir) residing in Karachi South. In conclusion, Pakistan at present falls into a low risk lung cancer region in females and a moderate risk region for males and the highest registered increase between 1995 and 2002 was observed in the older age groups (65+). It is however a cause of concern that the overall lung cancer incidence rates continue to rise. The age specific rates though stable in the younger age groups (35-49 years), are at present equivalent to contemporary rates in high- risk countries. These rates correspond with the trends of smoking prevalence in the younger age groups in the last 2 decades. Published studies have given alerts to increase in the smoking habits of the present day youngsters and with an expanding population the country can expect a substantial increase in lung cancer. This threat can only be averted by implementation of stringent anti-tobacco rules and health education; prohibition of smoking in educational institutions at all levels and a ban on the sale of cigarettes to minors.

Small round cell tumours of childhood a histopathological study

A retrospective study of 132 solid small round cell tumours of childhood were reviewed from the files of histopathology department of Saddam Medical City Teaching Hospital. Non-Hodgkin's lymphoma was the most frequent tumour, together with Hodgkin's disease, they comprised 47% of the total cases. These tumours were followed by neuroblastoma [18%], nephroblstoma [16%], Ewing's sarcoma [8%] and rhabdomyosarcoma [7%]. Despite differences in their light micro-scopical appearances, age, sex, and anatomical locations, 4.5% of these tumours were unclassifiable. Means to reduce the occurrence of the latter category is discussed

Prevalência de hipercalcemia em pacientes portadores de câncer de pulmäo / Prevalence of hypercalcemia in patients carriers of lung neoplasm

A hipercalcemia é uma das maiores freqüentes manifestaçöes paraneoplásicas, principalmente dentre as neoplasias malignas de pulmäo, mas ainda pouco valorizada em nosso meio. Neste trabalho estudamos a prevalência de hipercalcemia em uma populaçäo de pacientes portadores de tumor de pulmäo que freqüentaram o ambulatório específico da Escola Paulista de Medicina no Hospital Säo Paulo. Foram investigadso 90 pacientes assim distribuídos: 35 carcinomas espinocelulares (CEC), 30 adenocarcinomas (AdenoCa), 11 carcinomas indiferenciados de pequenas células (CIPC), 2 tumores de grandes células (RGC), 1 carcinóide, 1 mesotelioma, 2 indiferenciados, 1 adenoescamoso, 1 carcinoma in situ e 3 tumores metastáticos de origens diversas. Em todos estes pacientes foi dosado Ca ionizado (Ca-i) em amostras de sangue total. Nos pacientes em que se constataram níveis de Ca-i acima do limite de normalidade )>1,29 mmol/L), foram realizadas dosagens de paratormônio (PTH) sérico e AMP cíclico urinário para se afastar um possível hiperparatiroidismo como causa da hipercalcemia. Encontramos níveis de Ca-i elevados (variando de 1,3 a 2,0 mmol/L em 18 destes pacientes (20//), sendo: 12 CEC (66,7//), 3 AdenoCa (16,7//), 2 CIPC (11,1//) e 1 TGC (5,6//). O PTH estava baixo ou suprimido em todos os pacientes hipercalcêmicos, afastando, desta forma, um hiperparatiroidismo. A dosagem de AMP cíclico urinário näo se mostrou útil no diagnóstico diferencial, estando elevada em 6 dos 12 pacientes avaliados. Concluímos ser hipercalcemia um achado bastante comum em pacientes portadores de tumores de pulmäo, principalmente dentre os carcinomas espinocelulares, sendo seu diagnóstico sindrômico e etiológico de grande interesse para melhor tratamento desses pacientes